Alcohol Consumption the Day of Liver Transplantation for Alcohol‐Associated Liver Disease Does Not Affect Long‐Term Survival: A Case‐Control Study

José Ursic‐Bedoya, Jérôme Dumortier, Romain Altwegg, Mohamed Belkacemi, Claire Vanlemmens, Sébastien Dharancy, Camille Besch, Sarah Shili‐Masmoudi, Claire Francoz, Olivier Boillot, Magdalena Meszaros, Lucy Meunier, Stéphanie Faure, Astrid Herrero, Hélène Donnadieu‐Rigole, Georges‐Philippe Pageaux – 25 September 2020 – Alcohol abstinence before liver transplantation (LT) for alcohol‐associated liver disease (ALD) is required for every candidate. Some listed patients might relapse, resulting in LT for patients nonabstinent during the pretransplant period.

Promoterless, Nuclease‐Free Genome Editing Confers a Growth Advantage for Corrected Hepatocytes in Mice With Methylmalonic Acidemia

Randy J. Chandler, Leah E. Venturoni, Jing Liao, Brandon T. Hubbard, Jessica L. Schneller, Victoria Hoffmann, Susana Gordo, Shengwen Zang, Chih‐Wei Ko, Nelson Chau, Kyle Chiang, Mark A. Kay, Adi Barzel, Charles P. Venditti – 25 September 2020

Approaches to Research Determination of Late Acute Cellular Rejection in Pediatric Liver Transplant Recipients

George V. Mazariegos, Benjamin L. Shneider, Eyal Shemesh, Deborah Schady, Hector Melin‐Aldana, Soo‐Jin Cho, Ravinder Anand, Jinson Erinjeri, Rachel Annunziato, Miguel Reyes‐Mugica – 25 September 2020 – A central pathology or site reading of biopsy slides is used in liver transplant clinical trials to determine rejection. We evaluated interrater reliability of readings of “rejection or not” using digitized slides from the Medication Adherence in Children who had a Liver Transplant (MALT) study.

Effects of Cirrhosis and Diagnosis Scenario in Metabolic‐Associated Fatty Liver Disease‐Related Hepatocellular Carcinoma

Vincent L. Chen, Ming‐Lun Yeh, Ju Dong Yang, Jennifer Leong, Daniel Q. Huang, Hidenori Toyoda, Yao‐Li Chen, Jennifer Guy, Mayumi Maeda, Pei‐Chien Tsai, Chung‐Feng Huang, Satoshi Yasuda, An K. Le, Hansen Dang, Nasra H. Giama, Hamdi A. Ali, Ning Zhang, Xiaozhong Wang, Dae Won Jun, Cheng‐Hao Tseng, Yao‐Chun Hsu, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang, Qiang Zhu, Yock Young Dan, Myron Schwartz, Lewis R. Roberts, Ming‐Lung Yu, Mindie H.

Serum Matrix Metalloproteinase 7 Is a Diagnostic Biomarker of Biliary Injury and Fibrosis in Pediatric Autoimmune Liver Disease

Simon Lam, Ruchi Singh, Jonathan R. Dillman, Andrew T. Trout, Suraj D. Serai, Divya Sharma, Rachel Sheridan, Weizhe Su, Lin Fei, Rebekah Karns, Marija M. Haramija, Ged Ridgway, Marc Goldfinger, James E. Squires, Lee A. Denson, Jeffery S. Hyams, Alexander G. Miethke – 24 September 2020 – In autoimmune liver disease (AILD), including autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC), and overlap syndrome of AIH and PSC (ASC), the presence of biliary injury portends a worse prognosis.

LiverLearning®: 2020 Transplant Hepatology Board Review Course

The 2020 AASLD Transplant Hepatology Board Review Course set for August 15-16 in Dallas, TX is now an on-demand course. This on-demand course will release on Friday, August 15, 2020.  For further questions contact education@aasld.org. This course will help prepare physicians for the American Board of Internal Medicine (ABIM) and American Board of Pediatrics (ABP) certification and maintenance of certification (MOC) exam in transplant hepatology and pediatric transplant hepatology as it reflects the updated ABIM/ABP Transplant Hepatology Certification Exam blueprint.

Subscribe to